So back to what I was saying about
enolase not being the first or only autoantigen implicated in Lyme disease, here are a few things I found this morning that seemed interesting. Still can't find that darned OspA/ganglioside paper. I'm sure it's on my old computer somewhere. Anyways the important thing to remember here is that molecular mimicry is a very very VERY common event. However, not all molecular mimicry = lymphocyte activation. And not all Lymphocyte activation = autoimmune disease. Particularly when extrapolating from in vitro assays to actual disease processes. So we still don't know which autoantigens are responsible for disease symptoms. However, I think the potential here is really cool. Just to know how highly evolved this stupid little thing is to sneak around your body like that pretending to be a piece of you in every possible way that it can come up with. Blows my mind. I also think it helps us to remember that autoimmunity and infection are not separate processes. This is just HOW microorganisms cause illness. It's just a mechanism of injury. It's not a separate disease.
autoantibodies to cardiolipin and ganglioside in neuroborreliosis http://www.jns-journal.com/article/0022-510X(93)90175-X/pdf
This one doesn't talk about
OspA specifically, but immunization of whole cell borrelia inducing anti-gangliosides, a common cause of peripheral nerve disorders like CIDP/GBS https://www.ncbi.nlm.nih.gov/pubmed/7558329
Here's an interesting one. 856 peptides cross reactive to Borrelia OspA. Of those, 28 induced an inflammatory response. That doesn't mean they all play a role in disease, but it shows the potential here. "Our data together with other available evidence suggest that cross-reactivity leading to T cell activation is a very frequent event." And this was only in a limited selection of T-cells, and not including B-cells. And only to OspA at that! http://sci-hub.cc/10.1002/1521-4141(200002)30:2%3C
448::AID-IMMU448%3E
3.0.CO;2-9
This one, though small scale, is provocative in regards to causation. 6 patients develop CIDP and cognitive impairment after vaccination with OspA https://www.ncbi.nlm.nih.gov/pubmed/15363064
And on the topic of vaccines, OspA exacerbates arthritis in live infection (just because I know someone is going to freak out at the implications that a vaccine injury might undermine chronic Lyme. This model suggests live infection may still be necessary.) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC97189/
Post Edited (Psilociraptor) : 11/9/2017 6:30:47 AM (GMT-7)